Market Overview

Deutsche Bank Remains Bullish on Nu Skin Despite Recent Sharp Move Lower, Maintains Buy Rating

Share:
Related NUS
Mid-Day Market Update: Crude Oil Jumps 11%; Nu Skin Shares Tumble Following Weak Results
Mid-Morning Market Update: Markets Open Higher; Groupon Tops Q4 Expectations
Examining the Current State of Health Care and Skin Care Stocks (GuruFocus)

Bulls in shares of Nu Skin Enterprises (NYSE: NUS) are finally getting some relief Wednesday as an optimistic note from Deutsche Bank's Bill Schmitz is turning heads. The stock closed up more than 6 percent; shares have plunged about 50 percent over the last week.

Although Schmitz reduced his price target on Nu Skin shares from $150 to $115 in the note from late Tuesday, the analyst said he is maintaining a Buy rating.

The Deutsche Bank analyst believes investors are "currently discounting a significant decline in the company's Chinese business," creating an attractive entry point. He also pointed at a "pristine" balance sheet and fundamentals outside of China which "are still among best in class across the CPG universe."

With shares of Nu Skin closing Wednesday's trading session at $82.15, Schmitz's new, reduced price target implies potential upside of about 40 percent.

Latest Ratings for NUS

DateFirmActionFromTo
Apr 2016CitigroupMaintainsBuy
Feb 2016Sidoti & Co.DowngradesBuyNeutral
Feb 2016Stifel NicolausMaintainsSell

View More Analyst Ratings for NUS
View the Latest Analyst Ratings

Posted-In: Analyst Color News Price Target Analyst Ratings

 

Related Articles (NUS)

View Comments and Join the Discussion!